GTR Home > Tests > Search results - C1335929[DISCUI]

Apply filters

Showing tests for all 2193 conditions

Compare labs

Your search term can be found in tests with a total of 2193 conditions. Only 1000 conditions are displayed in this filter box. Please type the name of the condition in the search box in this filter to find the specific condition. You can use the filters below to narrow down your results.
If the name of the condition you typed is not present, please try another query or search using the All GTR tab.

  • Hide states

GTR test search results for C1335929[DISCUI]

C Clinical test, R Research test

Showing 1 to 20 of 30 tests for 2193 conditions in 18 labs

CSMARCB1

Lab: Cancer Genetics Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
Test targets
Methods
  • I FISH-interphase
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CFAMILIAL SCHWANNOMATOSI - SMARCB1/INI1 gene

Test targets
Methods
  • D Deletion/duplication analysis
  • L Linkage analysis
  • E Sequence analysis of select exons

CTruGenome Predisposition Screen (Whole Genome Sequencing)

Lab: Illumina Clinical Services Laboratory Illumina San Diego, California, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (1541)
Total targets (1578)

CSMARCA4. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Conditions
Test targets
Methods
  • C Sequence analysis of the entire coding region

CARID1B . Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Conditions
Test targets
Methods
  • C Sequence analysis of the entire coding region

CARID1A. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Conditions
Test targets
Methods
  • C Sequence analysis of the entire coding region

CSMARCB1. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Conditions
Test targets
Methods
  • C Sequence analysis of the entire coding region

CSMARCB1. MLPA testing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Conditions
Test targets
Methods
  • D Deletion/duplication analysis

CSMARCB1. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Conditions
Test targets
Methods
  • C Sequence analysis of the entire coding region

CSingle gene testing NF2

Lab: CeGaT GmbH Tuebingen, Baden-Wurttemberg, Germany
Test targets
Methods
  • C Sequence analysis of the entire coding region

CNeurocutaneous Panel

Total conditions (14)
Total targets (8)

CNGS RASopathy Panel

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (7)
Total targets (23)

CNeurofibromatosis NGS Panel

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (8)

CCancer Predisposition

Lab: Asper Biotech Asper Biotech Ltd. Tartu, Tartumaa, Estonia
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (134)
Total targets (100)

CCentral Nervous System Hereditary Cancer Panel, Sequencing and Deletion/Duplication, 15 Genes

Lab: ARUP Laboratories, Molecular Genetics Salt Lake City, Utah, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (21)
Total targets (15)

CNF2

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CSMARCB1

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CRenal/Kidney NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (72)
Total targets (22)

Showing 1 to 20 of 30 tests for 2193 conditions in 18 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.